Full Episode
Tuesday, Sep 9
PBS NewsHour
  • Episodes
  • Podcasts
  • Newsletters
  • The Latest
  • Politics
    Politics
    • Brooks and Capehart
    • Politics Monday
    • Supreme Court
  • Arts
    Arts
    • CANVAS
    • Poetry
    • Now Read This
  • Nation
    Nation
    • Supreme Court
    • Race Matters
    • Essays
    • Brief But Spectacular
  • World
    World
    • Agents for Change
  • Economy
    Economy
    • Making Sen$e
    • Paul Solman
  • Science
    Science
    • The Leading Edge
    • ScienceScope
    • Basic Research
    • Innovation and Invention
  • Health
    Health
    • Long-Term Care
  • Education
    Education
    • Teachers' Lounge
    • Student Reporting Labs
  • For Teachers
    Education
    • Newshour Classroom
  • About
    • Feedback
    • Funders
    • Support
    • Jobs

You asked for news you can trust.

We deliver with clarity and context in the moment.
Donate now
PBS News

Get news alerts from PBS News

Turn on desktop notifications?

obesity

  • Full Episodes
  • Podcasts
  • Newsletters
  • Live
A company logo is seen at a Pfizer office in Dublin

Health Apr 14

Pfizer abandons potential obesity treatment pill

By Tom Murphy, Associated Press

Health Mar 05

DENMARK-PHARMACEUTICAL-NOVONORDISK-EARNINGS-OBESITY
Novo Nordisk cuts Wegovy prices, following Eli Lilly on Zepbound

The new monthly price of $499, down from $650, takes effect immediately.

By Associated Press

Health Feb 12

FILE PHOTO: A injection pen of Novo Nordisk's weight-loss drug Wegovy is shown in this photo illustration in Oslo
Study suggests obesity drugs could help with alcohol cravings

A new study suggests that medications that have transformed the treatment of obesity may also help people drink less alcohol.

By Carla K. Johnson, Associated Press

Health Jan 15

FILE PHOTO: Boxes of Ozempic and Wegovy made by Novo Nordisk are seen at a pharmacy in London
Obesity won’t be solely defined by BMI under new plan for diagnosis by global experts

Under recommendations released Tuesday night, obesity would no longer be defined solely by BMI, a calculation of height and weight, but combined with other measurements, such as waist circumference, plus evidence of health problems tied to extra pounds.

By JoNel Aleccia, Associated Press

Health Jan 02

weight
Watch 6:00
As weight loss drug demand soars, physician outlines effectiveness and potential downsides

For weight loss drugs like Ozempic and Wegovy, 2024 was a big year. More patients are relying on them to manage their weight, treat diabetes, or prevent heart attacks and strokes. And while they are highly effective, they also come…

By William Brangham, Jackson Hudgins, Hamada Hanoura

Oct 26

Watch 8:07
Why more doctors are treating children and adolescents with weight loss drugs

By Ali Rogin, Satvi Sunkara

Physicians are increasingly using weight loss drugs to treat obesity, diabetes and other chronic conditions in young patients. In the last three years, the number of people between the ages of 12 and 25 using drugs like Wegovy and Ozempic…

Continue watching

Sep 24

Watch 3:57
Lawmakers challenge drug company CEO over steep prices for Ozempic and Wegovy

By William Brangham, Courtney Norris, Ryan Connelly Holmes

Ozempic and Wegovy are some of the most popular drugs in the country, driven by their remarkable success in treating diabetes and obesity. But the drugs are extremely expensive, and the drugmaker’s CEO appeared on Capitol Hill Tuesday to face…

Continue watching

Sep 24

Obesity rates hold steady, but severe obesity is on the rise

By JoNel Aleccia, Associated Press

Experts say preventing obesity in the first place is key, starting in early childhood.

Continue reading

Jun 17

Watch 8:38
The many ways new weight loss drugs could transform the economy

By Catherine Rampell, Diane Lincoln Estes

Last year, Americans spent over $50 billion on weight loss drugs like Ozempic and Wegovy. Their popularity, and their price, are having effects throughout the economy. PBS News Hour special correspondent and Washington Post columnist Catherine Rampell reports.

Continue watching

Dec 28

Watch 7:59
Physician discusses surge in demand for weight-loss drugs and risks in using them

By Ali Rogin, Karina Cuevas

One of the biggest health stories of this past year is the surge in demand for popular weight-loss drugs like Ozempic and Wegovy. Those drugs are in such demand that there’s a nationwide shortage of them. Pharmaceutical companies are scrambling…

Continue watching

Jump to the First Page Previous Page
1 2 3 4 5 6 7 8 9 10
Next Page Jump to the Last Page

Support Provided By: Learn more

web ad

Educate your inbox

Subscribe to Here’s the Deal, our politics newsletter for analysis you won’t find anywhere else.

Form error message goes here.

Thank you. Please check your inbox to confirm.

Full Episode
Tuesday, Sep 9
  • BDO
  • BNSF Railway
  • Consumer Cellular
  • Raymond James
  • Viewers Like You
  • Friends of the News Hour
PBS News

© 1996 - 2025 NewsHour Productions LLC. All Rights Reserved.

PBS is a 501(c)(3) not-for-profit organization.

Sections

  • The Latest
  • Politics
  • Arts
  • Nation
  • World
  • Economy
  • Science
  • Health
  • Education

About

  • About Us
  • TV Schedule
  • Press
  • Feedback
  • Funders
  • Support
  • Newsletters
  • Podcasts
  • Jobs
  • Privacy
  • Terms of Use

Stay Connected

  • Facebook
  • YouTube
  • Instagram
  • X
  • TikTok
  • Threads
  • RSS

Subscribe to Here's the Deal with Lisa Desjardins

Form error message goes here.

Thank you. Please check your inbox to confirm.

Support our journalism

Support for News Hour Provided By

  • BDO
  • BNSF Railway
  • Consumer Cellular
  • Raymond James
  • Viewers Like You